Just before the 23andMe SPAC deal closed, the stock belonging to its merger ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets ...

Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...

The U.S. Federal Trade Commission is concerned about the potential sale or transfer of Americans' personal information by 23andMe ME.O ancestry testing company which recently filed for ...

23andme says it owns the aggregated genetic data of its customers, meaning it can sell it to the highest bidder ...

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

Genetic analysis company 23andMe (ME) announced this week it's declaring bankruptcy and pursuing a sale, leading many customers to pursue deleting their data from the company. 23andMe was founded ...

23andMe is going bankrupt — underscoring the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations. When companies opt ...

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...

Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...